<DOC>
	<DOCNO>NCT01393483</DOCNO>
	<brief_summary>The purpose study find whether protein , call mesothelin , find blood tissue use `` marker '' esophageal cancer . Doctors Memorial Sloan-Kettering Cancer Center would like compare level protein patient abnormal cell tissue esophageal level protein patient treat cancer esophagus .</brief_summary>
	<brief_title>Evaluate Mesothelin Biomarker Clinical Management Esophageal Adenocarcinoma ( EAC )</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Patients T1 adenocarcinoma suspect adenocarcinoma schedule biopsy mucosal resection ( Group 1 ) Patients T12N0 adenocarcinoma suspect adenocarcinoma schedule undergo esophagectomy ( Group 2 ) Patients T2N1 T3N01 adenocarcinoma suspect adenocarcinoma schedule undergo endoscopy biopsy and/or endoscopic ultrasound biopsy prior preoperative chemoradiotherapy baseline surgical tissue available staining ( Group 3 ) Patients &lt; 18 year age Patients unfit medically endoscopy surveillance therapy Patients unfit medically esophagectomy Patients stage IV esophageal adenocarcinoma Patients previously treat chemoradiotherapy esophageal cancer Patients squamous cell carcinoma esophagus Patients history cancer within 3 year concurrent cancer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>esophagectomy</keyword>
	<keyword>endoscopy</keyword>
	<keyword>biopsy</keyword>
	<keyword>Tissue mesothelin</keyword>
	<keyword>Serum mesothelin</keyword>
	<keyword>11-037</keyword>
</DOC>